Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01874665 |
Title | A Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor |
Acronym | GIST |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Ariad Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | |
Covered Countries | USA |